期刊文献+

EVAc膜及促进剂对左炔诺孕酮人皮肤渗透速率的影响 被引量:4

Effects of EVAc membrane and enhancers on levonorgestrel permeation rate through human skin
下载PDF
导出
摘要 目的:测定不同厚度、不同醋酸乙烯(VAc)含量的乙烯醋酸乙烯控释膜(EVAc)及不同促进剂对左炔诺孕酮(LNG)人皮肤渗透速率的影响。方法:采用ValiaChien渗透池与HPLC测定以上不同条件下LNG/体积分数为70%的乙醇(EtOH)饱和液中LNG人皮肤渗透速率。结果:LNG的皮肤/膜渗透速率随控释膜厚度的增加而减少,控释膜厚度的倒数与LNG皮肤渗透速率呈良好的线性关系,r=0.9929。控释膜中VAc含量(280,180,140g·kg-1)会影响LNG的渗透速率,以280g·kg-1VAc为最高,140g·kg-1VAc最低。促进剂(20g·kg-1油酸或20g·kg-1月桂氮酮)能明显增加LNG的人皮肤渗透速率。结论:以20g·kg-1油酸为促进剂,50μm,280g·kg-1VAc的EVAc膜为控释膜时。 OBJECTIVE:To investigate effects of ethylene/vinyl acetate copolymer(EVAc) membrane with various weight fraction rate of vinyl acetate,different membrane thickness and different skin permeation enhancers on levonorgestrel permeation rate through human skin.METHODS:The Valia Chien permeation cells and HPLC were used to determine the permeation of LNG in 70% ethanol saturated solution under the above different conditions.RESULTS:The permeation rate of LNG through EVAc membrane covered human skin showed a zero order permeation kinetics,with rate increased as increasing the weight fraction of vinyl acetate in the copolymer(280 g·kg -1 >180 g·kg -1 >140 g·kg -1 ),but decreased as increasing the thickness of membrane.The permeation rate was proportional to the reciprocal of the membrane thickness(r=0.992 9).Enhancers(20 g·kg -1 oleicacid and 20 g·kg -1 azone) can further increase the permeation of LNG.CONCLUSION:The skin permeation rate of LNG can meet the requirement with 20 g·kg -1 OA and proper EVAc member(50 μm,280 g·kg -1 VAc).
出处 《中国药学杂志》 CAS CSCD 北大核心 1998年第11期665-668,共4页 Chinese Pharmaceutical Journal
关键词 左炔诺孕酮 EVAc膜 皮肤渗透 控释 levonorgestrel,ethylene/vinyl acetate(EVAc) membrane,skin permeation,controlled delivery
  • 相关文献

参考文献4

二级参考文献1

  • 1Yie W. Chien,Te-yen Chien,Robert E. Bagdon,Yih C. Huang,Robert H. Bierman. Transdermal Dual-Controlled Delivery of Contraceptive Drugs: Formulation Development, in Vitro and in Vivo Evaluations, and Clinical Performance[J] 1989,Pharmaceutical Research(12):1000~1010

共引文献7

同被引文献30

  • 1唐小玲,李年丰,潘一峰,方小玲.左炔诺孕酮纳米粒缓释给药系统的研究[J].中国医学工程,2004,12(6):16-18. 被引量:5
  • 2陈国神,龚赛君,王俏,周蓉蓉.雌二醇透皮给药系统控释机理研究[J].中国医药工业杂志,1994,25(1):8-10. 被引量:4
  • 3SHULMAN L P. 17 Beta-estradiol/levonorgestrel transdermal system for the management of the symptomatic menopausal woman[J]. Expert Opin Pharmacother, 2004, 5(12): 2559-2566.
  • 4VON HOLST T, SALBACH B. Efficacy of a new 7-day transdermal sequential estradiol/levonorgestrel patch in women[J]. Maturitas, 2002, 41(3): 231-242.
  • 5CHEN G S, KIM D D, CHIEN Y W. Dual-controlled transdermal delivery of levonorgestrel and estradiol: enhanced permeation and modulated delivery[J]. J Controlled Release, 1995, 34:129-143.
  • 6FRIEND D, CATZ P, HELLER J, et al. Transdermal delivery of levonorgestrel Ⅰ: Alkanols as permeation enhancers in vitro[J]. J Controlled Release, 1988, 7: 243-250.
  • 7FRIEND D R, CATZ P, HELLER J, et al. Transdermal delivery of levonorgestrel Ⅳ: Evaluation of membranes[J]. J Pharm Sci, 1989, 78(6): 477-480.
  • 8LANDGREN B M, AEDO A R, JOHANNISSON E, et al. Studies on a vaginal ring releasing levonorgestrel at an initial rate of 27 micrograms/24 h when used alone or in combination with transdermal systems releasing estradiol[J]. Contraception, 1994, 50(1): 87-100.
  • 9FRIEND D R, CATZ P, PHILLIPS S. Transdermal delivery of levonorgestrel. VII. In vivo studies[J]. Contraception, 1989, 40(1): 73-80.
  • 10FRIEND D R. Transdermal delivery of levonorgestrel[J]. Med Res Rev, 1991, 11(1): 49-80.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部